ADT 2010 Annual Report Download - page 21

the board include his broad international leadership experience as an executive at Rohm and Haas, his
engineering and science background, and his corporate governance experience as a board member and
executive in several publicly traded and private companies.
John A. Krol—Mr. Krol, age 74, joined our Board in August 2002. Mr. Krol served as the
Chairman and Chief Executive Officer of E.I. du Pont de Nemours & Company, where he spent his
entire career until his retirement in 1998. E.I. du Pont de Nemours is a global research and technology-
based company serving worldwide markets, including food and nutrition, health care, agriculture,
fashion and apparel, home and construction, electronics and transportation. Mr. Krol also serves as a
director of ACE Limited, and the private companies Delphi Automotive, LLP (where he is chairman of
the board), Norvax, Inc. and Pacolet-Milliken. He also served as a director of MeadWestvaco
Corporation, a global packaging solutions company. Mr. Krol graduated from Tufts University where he
received a B.S. and M.S. in chemistry. Mr. Krol’s qualifications to serve on the board include his
extensive leadership and corporate governance experience as an executive and as the former chairman
and chief executive of DuPont, his engineering and science background and his well developed business
acumen gained over decades of experience as an advisor and as a board member of numerous publicly
traded and private companies.
Brendan R. O’Neill—Dr. O’Neill, age 62, joined our Board in March 2003. Dr. O’Neill was Chief
Executive Officer and director of Imperial Chemical Industries PLC (‘‘ICI’’), a manufacturer of
specialty products and paints, until April 2003. Dr. O’Neill joined ICI in 1998 as its Chief Operating
Officer and Director, and was promoted to Chief Executive Officer in 1999. Prior to Dr. O’Neill’s
career at ICI, he held numerous positions at Guinness PLC, including Chief Executive of Guinness
Brewing Worldwide Ltd, Managing Director International Region of United Distillers, and Director of
Financial Control. Dr. O’Neill also held positions at HSBC Holdings PLC, BICC PLC and the Ford
Motor Company. He has an M.A. from the University of Cambridge and a Ph.D. in chemistry from the
University of East Anglia, and is a Fellow of the Chartered Institute of Management Accountants
(U.K.). Dr. O’Neill is a director of Endurance Specialty Holdings Ltd., Informa plc and Towers
Watson, Inc. He chairs the Audit Committee of Informa plc. Dr. O’Neill was also a director of Rank
Group, a hospitality and leisure business from 2005 to 2007 and Aegis Group Plc, a global market
research company, from 2005 to 2009. Dr. O’Neill is the Chair of the Audit Committee. Dr. O’Neill is
qualified to serve on the board because of his extensive experience in executive positions, his service as
a director for a broad spectrum of international companies and his financial acumen and understanding
of accounting principles.
William S. Stavropoulos—Dr. Stavropoulos, age 71, joined our Board in March 2007.
Dr. Stavropoulos was the Chairman, President and Chief Executive Officer of Dow Chemical Company,
where his career spanned 39 years until his retirement in 2006. While at Dow, Dr. Stavropoulos served
in a variety of positions in research, marketing and general management. Dr. Stavropoulos graduated
from Fordham University with a B.S. in pharmaceutical chemistry and from the University of
Washington with a Ph.D. in medicinal chemistry. Dr. Stavropoulos serves as a director of Chemical
Financial Corporation and Teradata Corporation, and is non-executive chairman of Univar, Inc., a
private company. He is a trustee to the Fidelity Group of Funds and the Rollin M. Gerstacker
Foundation, on the advisory boards of Maersk Corporation and Metalmark Capital LLC and is a
special advisor to Clayton, Dubilier & Rice, LLC. Dr. Stavropoulos is also President and Founder of
the Michigan Baseball Foundation. Dr. Stavropoulos’ qualifications to serve on the board include his
extensive experience as an executive at Dow, his corporate governance experience gained from his role
as chairman and chief executive officer of Dow and as a director and advisor to other publicly traded
companies as well as his experience in the industrial sector.
Sandra S. Wijnberg—Ms. Wijnberg, age 54, joined our Board in March 2003. In March 2007,
Ms. Wijnberg was named Chief Administrative Officer of Aquiline Holdings LLC. From January 2000
to April 2006, Ms. Wijnberg was the Senior Vice President and Chief Financial Officer at Marsh &
McLennan Companies, Inc., a professional services firm with insurance and reinsurance brokerage,
2011 Proxy Statement 13